ECZEMA, ATOPIC
Clinical trials for ECZEMA, ATOPIC explained in plain language.
Never miss a new study
Get alerted when new ECZEMA, ATOPIC trials appear
Sign up with your email to follow new studies for ECZEMA, ATOPIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Eczema patients may need fewer injections: new study tests a step-down strategy
Disease control OngoingThis study looks at whether people with well-controlled atopic dermatitis (eczema) can safely take dupilumab less often without losing control of their disease. About 256 teens and adults who have been on the standard every-2-week dose for at least a year will either stay on that…
Matched conditions: ECZEMA, ATOPIC
Phase: PHASE4 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated May 26, 2026 08:37 UTC
-
New eczema pill shows promise in Mid-Stage trial
Symptom relief OngoingThis study tests an experimental daily pill (PF-08049820) for adults with moderate to severe eczema (atopic dermatitis) who have not found a suitable prescription treatment. About 200 participants will take either the study drug or a placebo for 12 weeks, and researchers will tra…
Matched conditions: ECZEMA, ATOPIC
Phase: PHASE2 • Sponsor: Pfizer • Aim: Symptom relief
Last updated May 22, 2026 14:05 UTC